SynthesisMedical oncology (Northwood, London, England)2020

To be or not to be: whether anti-angiogenic agent combined with immune checkpoint inhibitoris necessary in the treatment of advanced or metastatic renal cell carcinoma.

Leitao Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.